Alpine Bank Wealth Management Edwards Lifesciences Corp Transaction History

Alpine Bank Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	BUY	$73.75 - $81.83 $9,956 - $11,047	135 Added 10.74%	1,392 $108 Million
Q2 2025 Jul 17, 2025	BUY	$67.07 - $78.22 $10,664 - $12,436	159 Added 14.48%	1,257 $98.3 Million
Q1 2025 Apr 23, 2025	BUY	$67.95 - $76.19 $44,031 - $49,371	648 Added 144.0%	1,098 $79.6 Million
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $26,865 - $42,201	450 New	450 $29.7 Million

1,465

468M

3.46M

4.07M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Alpine Bank Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Alpine Bank Wealth Management with notifications on news.